EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

The Effect of Pericapsular Nerve Group Block with Liposomal Bupivacaine on Postoperative Rebound Pain in Older Hip Fracture Patients: A Randomized Controlled Trial

Qiang Wang iD, Jiyuan Wang, Yujia Liu, Zhen Dai, Yan Wang, Xiaoqiong Xia, Yuanhai Li

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s562733 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Qiang Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Anesthesiology Department, The Fourth Affiliated Hospital of Anhui Medical University, ChaoHu, Hefei, People's Republic of China. Hauptthemen laut MEDLINE: Bupivacaine, Postoperative Pain, Hip Fractures, Nerve Block. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aims to investigate and discuss the effect of pericapsular nerve group (PENG) block with liposomal bupivacaine (LB) on postoperative rebound pain following hip fracture in older adults. Patients and Methods: Ninety patients scheduled for hip fracture surgery were randomized into three groups: LB (liposomal bupivacaine, 30 mL), R (0.375% ropivacaine, 30 mL), and C (saline, 30 mL). MAP and HR were recorded at T1 (pre-induction), T2 (post-intervention), and T3 (skin incision). NRS scores were evaluated at 12-72 h postoperatively, along with rebound pain, quadriceps function, analgesic consumption, and adverse reactions.

Results

The incidence of rebound pain was significantly lower in the LB and R groups than in the C group (p < 0.05). The AUC of NRS scores over 72 hours was significantly lower in the LB group (2.053 ± 1.258) than in the R (3.600 ± 2.087) and C (4.880 ± 2.739) groups (p < 0.0001). Hemodynamic analysis revealed significant differences in HR between T2 and T3 in all groups (LB: 77.10 ± 11.28 vs 73.77 ± 8.47; R: 79.57 ± 8.05 vs 74.00 ± 8.13; C: 80.50 ± 8.71 vs 84.13 ± 8.07; p < 0.05). MAP in the LB group differed significantly from Group C across the three time points (p < 0.05). There were no significant differences between the groups in adverse events.

Conclusion

LB PENG blockade reduces rebound pain incidence post-nerve block in elderly hip fracture patients, decreases PCA demand, preserves quadriceps function, and enhances satisfaction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BupivacainePostoperative PainHip FracturesNerve BlockAnesthetics, LocalHumansFemaleMaleLiposomesAgedAged, 80 and over

Stichwörter der Autor:innen

PENG blockhip fractureliposomal bupivacainerebound pain after nerve block

Substanzen

BupivacaineLiposomesAnesthetics, Local

Autor:innen und Institutionen

  • Anesthesiology Department, The Fourth Affiliated Hospital of Anhui Medical University, ChaoHu, Hefei, People's Republic of China.
  • Anesthesiology Department, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.

ORCID-Profile: Qiang Wang

Zitieren

APA

Wang, Q., Wang, J., Liu, Y., Dai, Z., Wang, Y., Xia, X., & Li, Y. (2025). The Effect of Pericapsular Nerve Group Block with Liposomal Bupivacaine on Postoperative Rebound Pain in Older Hip Fracture Patients: A Randomized Controlled Trial. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s562733

Vancouver

Wang Q, Wang J, Liu Y, Dai Z, Wang Y, Xia X, et al. The Effect of Pericapsular Nerve Group Block with Liposomal Bupivacaine on Postoperative Rebound Pain in Older Hip Fracture Patients: A Randomized Controlled Trial. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s562733

BibTeX
@article{Wang2025,
  author = {Wang, Qiang and Wang, Jiyuan and Liu, Yujia and Dai, Zhen and Wang, Yan and Xia, Xiaoqiong and Li, Yuanhai},
  title = {The Effect of Pericapsular Nerve Group Block with Liposomal Bupivacaine on Postoperative Rebound Pain in Older Hip Fracture Patients: A Randomized Controlled Trial},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s562733}
}
Kostenlos starten →